BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 32949098)

  • 1. The pediatric solid organ transplant experience with COVID-19: An initial multi-center, multi-organ case series.
    Goss MB; Galván NTN; Ruan W; Munoz FM; Brewer ED; O'Mahony CA; Melicoff-Portillo E; Dreyer WJ; Miloh TA; Cigarroa FG; Ranch D; Yoeli D; Adams MA; Koohmaraie S; Harter DM; Rana A; Cotton RT; Carter B; Patel S; Moreno NF; Leung DH; Goss JA
    Pediatr Transplant; 2021 May; 25(3):e13868. PubMed ID: 32949098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuated early inflammatory response in solid organ recipients with COVID-19.
    Bösch F; Börner N; Kemmner S; Lampert C; Jacob S; Koliogiannis D; Stangl M; Michel S; Kneidinger N; Schneider C; Fischereder M; Irlbeck M; Denk G; Werner J; Angele MK; Guba MO
    Clin Transplant; 2020 Oct; 34(10):e14027. PubMed ID: 32589760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heart transplant recipients with confirmed 2019 novel coronavirus infection: The Detroit experience.
    Al-Darzi W; Aurora L; Michaels A; Cowger J; Grafton G; Selektor Y; Tita C; Hannawi B; Lanfear D; Nemeh HW; Williams CT
    Clin Transplant; 2020 Dec; 34(12):e14091. PubMed ID: 32940925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 in solid organ transplant recipients: Dynamics of disease progression and inflammatory markers in ICU and non-ICU admitted patients.
    Roberts MB; Izzy S; Tahir Z; Al Jarrah A; Fishman JA; El Khoury J
    Transpl Infect Dis; 2020 Oct; 22(5):e13407. PubMed ID: 32654303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outpatient management of kidney transplant recipients with suspected COVID-19-Single-center experience during the New York City surge.
    Mehta SA; Leonard J; Labella P; Cartiera K; Soomro I; Neumann H; Montgomery RA; Ali NM
    Transpl Infect Dis; 2020 Dec; 22(6):e13383. PubMed ID: 32578324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 pneumonia in kidney transplant recipients: Focus on immunosuppression management.
    Chen TY; Farghaly S; Cham S; Tatem LL; Sin JH; Rauda R; Ribisi M; Sumrani N
    Transpl Infect Dis; 2020 Oct; 22(5):e13378. PubMed ID: 32573882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An early experience of COVID-19 disease in pediatric and young adult renal transplant recipients.
    Solomon S; Pereira T; Samsonov D
    Pediatr Transplant; 2021 Aug; 25(5):e13972. PubMed ID: 33502074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Varied clinical presentation and outcome of SARS-CoV-2 infection in liver transplant recipients: Initial experience at a single center in Madrid, Spain.
    Loinaz C; Marcacuzco A; Fernández-Ruiz M; Caso O; Cambra F; San Juan R; Justo I; Calvo J; García-Sesma A; Manrique A; Pérez-Jacoiste Asín MA; Folgueira MD; Aguado JM; Lumbreras C
    Transpl Infect Dis; 2020 Oct; 22(5):e13372. PubMed ID: 32562561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low rate of COVID-19 pneumonia in kidney transplant recipients-A battle between infection and immune response?
    Ghaffari Rahbar M; Nafar M; Khoshdel A; Dalili N; Abrishami A; Firouzan A; Poorrezagholi F; Samadian F; Ziaie S; Fatemizadeh S; Samavat S
    Transpl Infect Dis; 2020 Oct; 22(5):e13406. PubMed ID: 32654357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 infection in pediatric solid organ transplant patients.
    Bansal N; Ovchinsky N; Foca M; Lamour JM; Kogan-Liberman D; Hsu DT; Beddows K; Abraham L; Coburn M; Cunningham R; Nguyen T; Hayde N
    Pediatr Transplant; 2022 Mar; 26(2):e14156. PubMed ID: 34633125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 in solid organ transplant recipients: a single-center experience.
    Hoek RAS; Manintveld OC; Betjes MGH; Hellemons ME; Seghers L; Van Kampen JAA; Caliskan K; van de Wetering J; van den Hoogen M; Metselaar HJ; Hesselink DA;
    Transpl Int; 2020 Sep; 33(9):1099-1105. PubMed ID: 32460390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of COVID-19 in liver transplant recipients: A preliminary report from Northwestern Italy.
    Patrono D; Lupo F; Canta F; Mazza E; Mirabella S; Corcione S; Tandoi F; De Rosa FG; Romagnoli R
    Transpl Infect Dis; 2020 Oct; 22(5):e13353. PubMed ID: 32500942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early report from the Pediatric Heart Transplant Society on COVID-19 infections in pediatric heart transplant candidates and recipients.
    Conway J; Auerbach SR; Richmond ME; Sharp B; Pahl E; Feingold B; Azeka E; Dryer WJ; Cantor RS; Kirklin JK;
    J Heart Lung Transplant; 2022 Mar; 41(3):327-333. PubMed ID: 34903451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful liver transplantation in a patient recovered from COVID-19.
    Dhand A; Bodin R; Wolf DC; Schluger A; Nabors C; Nog R; Diflo T; Nishida S
    Transpl Infect Dis; 2021 Apr; 23(2):e13492. PubMed ID: 33040430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A proposed strategy for management of immunosuppression in heart transplant patients with COVID-19.
    Ahluwalia M; Givertz MM; Mehra MR
    Clin Transplant; 2020 Nov; 34(11):e14032. PubMed ID: 32621523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial Report From a Swedish High-volume Transplant Center After the First Wave of the COVID-19 Pandemic.
    Felldin M; Søfteland JM; Magnusson J; Ekberg J; Karason K; Schult A; Larsson H; Oltean M; Friman V
    Transplantation; 2021 Jan; 105(1):108-114. PubMed ID: 32826796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges in heart transplantation during COVID-19: A single-center experience.
    Singhvi A; Barghash M; Lala A; Mitter SS; Parikh A; Oliveros E; Rollins BM; Brunjes DL; Alvarez-Garcia J; Johnston E; Ryan K; Itagaki S; Moss N; Pinney SP; Anyanwu A; Mancini D
    J Heart Lung Transplant; 2020 Sep; 39(9):894-903. PubMed ID: 32891266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for unfavorable outcome and impact of early post-transplant infection in solid organ recipients with COVID-19: A prospective multicenter cohort study.
    Salto-Alejandre S; Jiménez-Jorge S; Sabé N; Ramos-Martínez A; Linares L; Valerio M; Martín-Dávila P; Fernández-Ruiz M; Fariñas MC; Blanes-Juliá M; Vidal E; Palacios-Baena ZR; Hernández-Gallego R; Carratalá J; Calderón-Parra J; Ángeles Marcos M; Muñoz P; Fortún-Abete J; Aguado JM; Arnaiz-Revillas F; Blanes-Hernández R; de la Torre-Cisneros J; López-Cortés LE; García de Vinuesa-Calvo E; Rosso CM; Pachón J; Sánchez-Céspedes J; Cordero E;
    PLoS One; 2021; 16(4):e0250796. PubMed ID: 33914803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variation in immunosuppression practices among pediatric liver transplant centers-Society of Pediatric Liver Transplantation survey results.
    Slowik V; Lerret SM; Lobritto SJ; Voulgarelis S; Vitola BE
    Pediatr Transplant; 2021 Mar; 25(2):e13873. PubMed ID: 33026158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.